SCHEMBL4905671

SCHEMBL4905671

C=Cc1ccccc1C(=O)OCCN(C)C

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 2/20 0.47
SCN2A Q99250 2/20 0.47
SCN3A Q9NY46 2/20 0.47
PHLPP2 Q6ZVD8 1/20 0.47
ALDH1A1 P00352 5/20 0.46
TSHR P16473 4/20 0.45
CYP3A4 P08684 2/20 0.45
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
POLR1A O95602 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 1/20 0.43
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28245601 0.84 ALDH1A1 (0.63) SCN1ASCN2ASCN3APHLPP2ALDH1A1
SCHEMBL4905609 0.83 ALDH1A1 (0.69) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL1896572 0.81 CYP3A4 (0.50) SCN1ASCN2ASCN3AALDH1A1TSHR
SCHEMBL4371870 0.81 CYP3A4 (0.50) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL1397837 0.81 TSHR (0.71) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL1897234 0.80 CYP3A4 (0.49) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL2002577 0.80 TSHR (0.67) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL30385424 0.80 TSHR (0.67) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL4906053 0.79 TSHR (0.49) ALDH1A1TSHRCYP3A4TDP1L3MBTL1
SCHEMBL4894269 0.79 TSHR (0.71) ALDH1A1TSHRCYP3A4TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080003288-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2008-01-03 US disclosed
US-7204997-B2 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2007-04-17 US disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed